Schizophrenia is characterized by anomalous perceptual experiences (e.g., sensory irritation, inundation, and flooding) and specific alterations in visual perception. We aimed to investigate the effects of short-term antipsychotic medication on these perceptual alterations. We assessed 28 drug-naïve first episode patients with schizophrenia and 20 matched healthy controls at baseline and follow-up 8 weeks later. Contrast sensitivity was measured with steady-and pulsed-pedestal tests. Participants also received a motion coherence task, the Structured Interview for Assessing Perceptual Anomalies (SIAPA), and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Proton magnetic resonance spectroscopy was used to measure gammaaminobutyric acid (GABA) levels in the occipital cortex (GABA/total creatine [Cr] ratio). Results revealed that, comparing baseline and follow-up values, patients with schizophrenia exhibited a marked sensitivity reduction on the steady-pedestal test at low spatial frequency. Anomalous perceptual experiences were also significantly ameliorated. Antipsychotic medications had no effect on motion perception. RBANS scores showed mild improvements. At baseline, but not at follow-up, patients with schizophrenia outperformed controls on the steady-pedestal test at low spatial frequency. The dysfunction of motion perception (higher coherence threshold in patients relative to controls) was similar at both assessments. There were reduced GABA levels in schizophrenia at both assessments, which were not related to perceptual functions. These results suggest that antipsychotics dominantly affect visual contrast sensitivity and anomalous perceptual experiences. The prominent dampening effect on low spatial frequency in the steady-pedestal test might indicate the normalization of putatively overactive magnocellular retino-geniculo-cortical pathways.
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Introduction
Patients with schizophrenia often report anomalous perceptual experiences that are subjectively and phenomenologically different from hallucinations and other positive psychotic symptoms. These experiences include disturbingly high intensity of environmental stimuli, feelings of being flooded and inundated, and inability to focus attention to relevant details (Bunney et al., 1999; Klosterkötter et al., 2001; Phillipson and Harris, 1985) , which is most prevalent and severe in the auditory and visual sensory modalities (Bunney et al., 1999; Martín-Reyes et al., 2010; Mendoza Quiñones et al., 2007) .
In a series of studies, we explored the possible psychophysical correlates of anomalous perceptual experiences, with a special reference to the visual modality (Kéri et al., 2005; Kiss et al., 2010) . Initially, we used the framework of the retino-geniculo-cortical magnocellular (M) and parvocellular (P) visual pathways, which originate in the retina and are theoretically responsible for the processing of different kinds of stimulus features (M pathways: low spatial frequencies [rough resolution of objects], luminance contrast, motion; P pathways: high spatial frequencies [fine resolution of objects], color contrast, form) (Nassi and Callaway, 2009). However, despite the fact that this perceptual hypothesis received an extensive attention in the literature of schizophrenia (e.g., reviewed by Butler et al., 2008; Javitt, 2009) , the exact psychophysical distinction of M and P pathways has been debated (Goodbourn et al., 2012; Merigan and Maunsell, 1993; Skottun and Skoyles, 2007) .
During past decades of research, Pokorny and colleagues developed a new method for the separation of putative M and P pathways, which 
